Skip to main content

. 1982 Apr;13(4):577–578. doi: 10.1111/j.1365-2125.1982.tb01426.x

Intravenous propranolol in patients with inflammation.

D G Waller, C L Smith, A G Renwick, C F George

PMCID: PMC1402065 PMID: 7066175

577

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

McDevitt D. G., Frisk-Holmberg M., Hollifield J. W., Shand D. G. Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther. 1976 Aug;20(2):152–157. doi: 10.1002/cpt1976202152. [DOI] [PubMed] [Google Scholar]
Nation R. L., Peng G. W., Chiou W. L. High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma. J Chromatogr. 1978 May 1;145(3):429–436. doi: 10.1016/s0378-4347(00)81372-9. [DOI] [PubMed] [Google Scholar]
Parsons R. L., Kaye C. M., Raymond K., Trounce J. R., Turner P. Absorption of propranolol and practolol in Coeliac disease. Gut. 1976 Feb;17(2):139–143. doi: 10.1136/gut.17.2.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
Piafsky K. M., Borgá O., Odar-Cederlöf I., Johansson C., Sjöqvist F. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. N Engl J Med. 1978 Dec 28;299(26):1435–1439. doi: 10.1056/NEJM197812282992604. [DOI] [PubMed] [Google Scholar]
Schneider R. E., Babb J., Bishop H., Mitchard M., Hoare A. M. Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease. Br Med J. 1976 Oct 2;2(6039):794–795. doi: 10.1136/bmj.2.6039.794. [DOI] [PMC free article] [PubMed] [Google Scholar]
Schneider R. E., Bishop H., Hawkins C. F. Plasma propranolol concentrations and the erythrocyte sedimentation rate. Br J Clin Pharmacol. 1979 Jul;8(1):43–47. doi: 10.1111/j.1365-2125.1979.tb05907.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES